Moderna, BioNTech, Pfizer stocks rally after AstraZeneca COVID-19 vaccine trial is reportedly haltedMarket Watch • 09/09/20
Should Investors Worry About Moderna Slowing Enrollment in Its Coronavirus Vaccine Trial?The Motley Fool • 09/09/20
Moderna Analyst Downgrades COVID-19 Vaccine Developer, Sees 'Changing Competitive Environment'Benzinga • 09/08/20
SVB analysts downgrade Moderna's stock, citing 'competitive pressure' from other COVID vaccine developersMarket Watch • 09/08/20
Nine biopharma CEOs pledge to make safety the main focus in coronavirus vaccine developmentCNBC • 09/08/20
Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political PressureThe Motley Fool • 09/05/20
Moderna Pulling Back on Coronavirus Vaccine Trial Enrollment to Get More Minority Patients InvolvedThe Motley Fool • 09/04/20
Moderna's stock falls 4% as CEO says enrollment in vaccine trial has been slowed to ensure diversityMarket Watch • 09/04/20
Moderna slows coronavirus vaccine trial enrollment to ensure minority representation, CEO saysCNBC • 09/04/20